Skip to main content
Top
Published in: Intensive Care Medicine 12/2013

01-12-2013 | What's New in Intensive Care

Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century

Authors: Jordi Rello, Bárbara Borgatta, Thiago Lisboa

Published in: Intensive Care Medicine | Issue 12/2013

Login to get access

Excerpt

Along with Staphylococcus aureus, Pseudomonas aeruginosa (PSA) heads the list of pathogens associated with Hospital-acquired pneumonia [13]. Indeed, even in patients with appropriate empiric antibiotic administration [3], the attributable mortality has been estimated to be 13.5 %. In survivors, PSA increases ICU length of stay and use of healthcare resources. In the early twenty-first century, the increase and dissemination of clones with progressive resistance are a cause of concern. In an international study of over 1,200 ICUs in 75 countries, the risk of infections, including those due to Pseudomonas species, was found to increase with duration of ICU stay; moreover, infection was also associated with an increased risk of mortality [1]. Therefore, understanding the epidemiology of this pathogen and identifying the risk factors the development of pneumonia should be a priority in research, and has obvious implications for infection control/prevention and therapy. …
Literature
1.
go back to reference Vincent JL, Rello J, Marshall J, Silva C, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infections in intensive care units. JAMA 302:2323–2329PubMedCrossRef Vincent JL, Rello J, Marshall J, Silva C, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, EPIC II Group of Investigators (2009) International study of the prevalence and outcomes of infections in intensive care units. JAMA 302:2323–2329PubMedCrossRef
2.
go back to reference Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D’Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2013) Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 39(4):682–692 Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D’Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T (2013) Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 39(4):682–692
3.
go back to reference Rello J, Jubert P, Valles J, Artigas A, Rué M, Niederman MS (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978PubMedCrossRef Rello J, Jubert P, Valles J, Artigas A, Rué M, Niederman MS (1996) Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 23:973–978PubMedCrossRef
4.
go back to reference Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, Prats G (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20:193–198PubMedCrossRef Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, Prats G (1994) Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med 20:193–198PubMedCrossRef
5.
go back to reference Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J (2007) Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35:1888–1895PubMedCrossRef Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J (2007) Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy. Crit Care Med 35:1888–1895PubMedCrossRef
6.
go back to reference Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP (2011) Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 37:632–638PubMedCrossRef Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP (2011) Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 37:632–638PubMedCrossRef
7.
go back to reference Venier AG, Gruson D, Lavigne T, Jarno P, L’Hériteau F, Coignard B, Savey A, Rogues AM, REA-RAISIN group (2011) Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN. J Hosp Infect 79:44–48PubMedCrossRef Venier AG, Gruson D, Lavigne T, Jarno P, L’Hériteau F, Coignard B, Savey A, Rogues AM, REA-RAISIN group (2011) Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN. J Hosp Infect 79:44–48PubMedCrossRef
8.
go back to reference Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, Agbaht K, Pobo A, Diaz E (2006) Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology 105:709–714PubMedCrossRef Rello J, Allegri C, Rodriguez A, Vidaur L, Sirgo G, Gomez F, Agbaht K, Pobo A, Diaz E (2006) Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure. Anesthesiology 105:709–714PubMedCrossRef
9.
go back to reference Leroy O, D’Escriban T, Devos P, Dubreuil L, Kipnis E, Georges H (2005) Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Infection 33:129–135PubMedCrossRef Leroy O, D’Escriban T, Devos P, Dubreuil L, Kipnis E, Georges H (2005) Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms. Infection 33:129–135PubMedCrossRef
10.
go back to reference Bonten MJM, Kollef MH, Hall JB (2004) Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 38:1141–1149PubMedCrossRef Bonten MJM, Kollef MH, Hall JB (2004) Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis 38:1141–1149PubMedCrossRef
11.
go back to reference Rello J, Ulldemolins M, Lisboa T, Koulenti D, Mañez R, Martin-Loeches I, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37:1332–1339PubMedCrossRef Rello J, Ulldemolins M, Lisboa T, Koulenti D, Mañez R, Martin-Loeches I, Martin-Loeches I, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2011) Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J 37:1332–1339PubMedCrossRef
12.
go back to reference Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Mañez R, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681PubMedCrossRef Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Mañez R, De Waele JJ, Putensen C, Guven M, Deja M, Diaz E, EU-VAP/CAP Study Group (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors. Intensive Care Med 39:672–681PubMedCrossRef
13.
go back to reference Leroy O, Jaffré S, D’Escrivan T, Devos P, Georges H, Alfandari S, Beaucaire G (2003) Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients. Chest 123:2034–2042PubMedCrossRef Leroy O, Jaffré S, D’Escrivan T, Devos P, Georges H, Alfandari S, Beaucaire G (2003) Hospital-acquired pneumonia: risk factors for antimicrobial-resistant causative pathogens in critically ill patients. Chest 123:2034–2042PubMedCrossRef
14.
go back to reference Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, Brown R, Hugenholtz P, DeSantis TZ, Andersen GL, Wiener-Kronish JP, Bristow J (2007) Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 45:1954–1962PubMedCrossRef Flanagan JL, Brodie EL, Weng L, Lynch SV, Garcia O, Brown R, Hugenholtz P, DeSantis TZ, Andersen GL, Wiener-Kronish JP, Bristow J (2007) Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol 45:1954–1962PubMedCrossRef
15.
go back to reference Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gilbert C (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34:1047–1054PubMedCrossRef Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gilbert C (2002) Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis 34:1047–1054PubMedCrossRef
Metadata
Title
Risk factors for Pseudomonas aeruginosa pneumonia in the early twenty-first century
Authors
Jordi Rello
Bárbara Borgatta
Thiago Lisboa
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 12/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-013-3046-1

Other articles of this Issue 12/2013

Intensive Care Medicine 12/2013 Go to the issue